Mobile health device links patients and healthcare professionals anytime, anywhere


Cambridge Consultants’ Minder, powered by Vena, arms patients with a pocket-sized ‘smart’ device that can reduce recovery times and hospital visits Cambridge Consultants, a leading technology product design and development firm, today announced a new product concept based on its low-cost Continua-compliant Vena platform.  The Minder, powered by Vena, enables continuous, real-time medical data collection …




Continue reading

Cambridge is urged to dig deep for Children in Need!


Your support for the Cambridge FunRun in aid of BBC Children in Need is urgently needed now! With many local companies weathering the recession well and recruiting vigorously, you might expect that next Friday’s 1.1 mile relay race on Cambridge Science Park would have attracted generous contributions… That does not appear to be the case. …




Continue reading

Astex and the NCIC Clinical Trials Group Announce Start of Phase II Clinical Study of AT9283 in Multiple Myeloma


Cambridge, UK, 4th November 2010. Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, and the NCIC Clinical Trials Group in Canada, announced today the initiation of a Phase II clinical trial of Astex’s combinatorial oncogenic kinase inhibitor, AT9283, to treat patients with relapsed or refractory multiple myeloma, an incurable blood …




Continue reading